News

Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea

Genio is a different approach to hypoglossal nerve stimulation (HGNS) for the treatment of OSA. Genio’s unique design ...

Nyxoah Announces Preliminary Results for the Second Quarter of 2025

Preliminary, Unaudited Second Quarter 2025 Financial Results and Business Updates Announced on August 8, 2025, that the U.S.
Zacks Investment Research on MSN21h

Nyxoah Secures FDA Clearance for Genio System to Treat Sleep Apnea

Nyxoah NYXH recently received FDA approval for its Genio system, an innovative therapy for moderate to severe Obstructive Sleep Apnea (OSA). Featuring a leadless, battery-free design powered by an ...
Pulmonology Advisor2d

FDA Clears Genio System for Obstructive Sleep Apnea

The FDA has approved the Genio system for the treatment of patients with moderate to severe obstructive sleep apnea.
InvestorsHub on MSN4d

Nyxoah Shares Climb Following FDA Clearance of Genio Device for Sleep Apnea Treatment

Nyxoah SA (NASDAQ:NYXH) saw its stock rise 9.4% after the FDA granted approval for its Genio system designed to treat ...
The College Fix1d

Tech expert to universities: Yes, it’s time to integrate AI — here’s how

“AI can be used as a gym – a place for training, challenge, and growth – or as a diet pill, a way to bypass effort in the ...
Medical Dialogues2d

FDA Approves Genio® System for Moderate to Severe OSA

The FDA has approved the Genio® system for treating patients with moderate to severe obstructive sleep apnea (OSA) with an ...
Fierce Biotech2d

Nyxoah plans US launch of sleep apnea implant, as rival Inspire lobs patent suit

After years of being cleared on the European market, Nyxoah’s neuromodulation therapy for obstructive sleep apnea has now ...